Ros Cutts

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial

Nicholas C. Turner, Belinda Kingston, Lucy Kilburn et al. · The Lancet Oncology · 2020 · 352 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer

Uzma Asghar, Alexis R. Barr, Ros Cutts et al. · Clinical Cancer Research · 2017 · 283 citations · Full text

Life Sciences, Cell Biology, Oncology +16

High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial

Alex Pearson, Elizabeth Smyth, Irina S. Babina et al. · Cancer Discovery · 2016 · 276 citations · Full text

Medicine, Cancer Biology, Oncology +17

Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer

Neha Chopra, Holly Tovey, Alex Pearson et al. · Nature Communications · 2020 · 262 citations · Full text

Medicine, Oncology, Pharmacology +16

Diverse <i>BRCA1</i> and <i>BRCA2</i> Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer

Britta Weigelt, Iñaki Comino‐Méndez, Ino de Bruijn et al. · Clinical Cancer Research · 2017 · 258 citations

Medicine, Molecular Genetics, Oncology +16